Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Transalta (TACPF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Transalta (TACPF) over the last 17 years, with Q3 2025 value amounting to $244.8 million.

  • Transalta's Cash & Equivalents fell 485.28% to $244.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $244.8 million, marking a year-over-year decrease of 485.28%. This contributed to the annual value of $246.1 million for FY2024, which is 456.77% down from last year.
  • Per Transalta's latest filing, its Cash & Equivalents stood at $244.8 million for Q3 2025, which was down 485.28% from $243.2 million recorded in Q2 2025.
  • In the past 5 years, Transalta's Cash & Equivalents registered a high of $1.2 billion during Q1 2022, and its lowest value of $234.9 million during Q1 2025.
  • For the 5-year period, Transalta's Cash & Equivalents averaged around $577.0 million, with its median value being $558.5 million (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 13716.76% in 2021, then crashed by 6958.2% in 2024.
  • Over the past 5 years, Transalta's Cash & Equivalents (Quarter) stood at $751.3 million in 2021, then rose by 11.2% to $835.4 million in 2022, then crashed by 69.4% to $255.6 million in 2023, then decreased by 5.62% to $241.2 million in 2024, then grew by 1.48% to $244.8 million in 2025.
  • Its Cash & Equivalents was $244.8 million in Q3 2025, compared to $243.2 million in Q2 2025 and $234.9 million in Q1 2025.